Modulation of HIVGP120 antigen-specific immune responses, in vitro and in vivo, by Delta9-tetrahydrocannabinol and cannabinoid receptors 1 and 2

"Approximately 25% of HIV patients use marijuana for its putative therapeutic benefit; however, it is unknown how cannabinoids affect the immune function of immunocompromised HIV patients at the early stage. The goal of these studies was to investigate the immunomodulatory effects of cannabinoids on the early stage of the anti-HIV immune responses... " -- Abstract.